Latest news
Cyclopharm (ASX:CYC) named preferred agent in first US lung imaging rewrite in 14 years - Stocks Down UnderStocks Down Under · Wed, 29 Jul 2026 07:00:00 GMTCyclopharm's Technegas Named Preferred Ventilation Agent in First US Lung Imaging Guideline Update in 14 Years - kalkine.com.aukalkine.com.au · Tue, 28 Jul 2026 23:15:02 GMTEarly-Stage Lung Cancer Diagnoses Rise Across the United States - OncodailyOncodaily · Tue, 28 Jul 2026 07:00:00 GMT